4//SEC Filing
LINNIK MATTHEW D 4
Accession 0001209191-06-067122
CIK 0000920465other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 5:19 PM ET
Size
9.6 KB
Accession
0001209191-06-067122
Insider Transaction Report
Form 4
LINNIK MATTHEW D
CSO & Exec VP of Research
Transactions
- Sale
Common Stock
2006-12-21$2.88/sh−5,000$14,394→ 1,665 total - Sale
Common Stock
2006-12-27$3.03/sh−365$1,106→ 1,300 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated as of November 1, 2006.
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001237521
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 5:19 PM ET
- Size
- 9.6 KB